Due Diligence for Medical Products: An FDA Regulatory and Supply Chain Perspective

In this webinar, our speakers highlight some of the most important FDA­ and supply chain-­related due diligence considerations for parties to transactions in the life sciences sector, and provide practical advice on addressing critical issues necessary to avoid downstream complications and unanticipated liabilities.

Topics

• Issues related to developing investigational medical products
• FDA applications
• Compliance with FDA's Current Good Manufacturing Practice (CGMP) regulation
• Government enforcement actions
• Supply chain safety concerns
• Implications of President Trump's August 2020 "Buy American" executive order
• Role of foreign regulatory bodies